Zhuolin Zhang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cost-effectiveness analysis of CYP2C19 genotype-guided antiplatelet therapy for patients with acute minor ischemic stroke and high-risk transient ischemic attack in China.
Journal: British journal of clinical pharmacology
Published: June 20, 2023
Impact of the national drug price negotiation policy on the utilization, cost, and accessibility of anticancer medicines in China: A controlled interrupted time series study.
Journal: Journal of global health
Published: December 17, 2022
Cost-effectiveness of preimplantation genetic testing for aneuploidy for women with subfertility in China: an economic evaluation using evidence from the CESE-PGS trial.
Journal: BMC pregnancy and childbirth
Published: December 02, 2022
Cost-Effectiveness of Pyrotinib Plus Capecitabine versus Lapatinib Plus Capecitabine for the Treatment of HER2-Positive Metastatic Breast Cancer in China: A Scenario Analysis of Health Insurance Coverage.
Journal: Current oncology (Toronto, Ont.)
Published: August 01, 2022
Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China.
Journal: Clinical drug investigation
Published: August 01, 2022
Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis.
Journal: Frontiers in public health
Published: April 05, 2022
Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions: A Mixed Longitudinal and Cross-Sectional Study in Jiangsu, China.
Journal: Frontiers in public health
Published: January 23, 2022
Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis.
Journal: Frontiers in public health
Published: May 19, 2021
Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis.
Journal: Therapeutics and clinical risk management
Published: February 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026